Locations:
Search IconSearch

Image of Note: 3-D Radiation-Free Navigation of the Aorta

Endovascular navigation technology clears first preclinical study

Centerline Biomedical IOPS

Endovascular repair of aortic aneurysms and dissections is critically dependent on optimal understanding of the patient’s vasculature. To that end, Cleveland Clinic Innovations spinoff company Centerline Biomedical Inc. is refining development of its Intraoperative Positioning System (IOPS), a novel endovascular navigation technology developed by Cleveland Clinic researchers.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

IOPS extracts the centerlines of the aorta and branch vessels from a patient’s CT and then mathematically constructs a high-quality three-dimensional model of the relevant vasculature, as shown in the image above. Electromagnetic tracking technology allows the model to be used in a GPS-like fashion to guide surgeons during minimally invasive endovascular aortic repairs, enabling less reliance on X-ray fluoroscopy.

The first preclinical in vivo study of IOPS was completed in May 2016 at Cleveland Clinic Lerner Research Institute. It demonstrated the system’s ability to provide non-radiation-based navigation with superior visualization compared with X-ray fluoroscopy, which is limited by its two-dimensional visualization and by the radiation exposure it confers on patients and providers.

“Preclinical evaluation verified the ability to use this navigation system in manipulating through the aorta and its branches in the absence of radiation-inducing fluoroscopy,” says Cleveland Clinic vascular surgeon Matthew Eagleton, MD, who led the study. Noting that catheters and guidewires were easily visualized on the IOPS display, he predicted that the system “will be a game changer in the era of endovascular therapy.”

Centerline Biomedical plans to submit IOPS for FDA review, with a target market entry in the third quarter of 2017.

Advertisement

Related Articles

female hands holding a pharmaceutical injector

GLP-1 RAs Show Survival and Cardiovascular Benefits in Patients With HFrEF and Diabetes

Large retrospective analysis may prompt prospective studies

doctor taking pulse of a woman in an exam room

Counseling Patients on the New Cholesterol Guideline: What Providers Should Know

How to talk about lifetime risk, treatment goals, Lp(a) testing, statin skepticism and more

stylized heart and lungs with text overlay

Highlights of Our Heart Failure and Electrophysiology Outcomes

A scannable recap of recent volumes and clinical metrics from Cleveland Clinic

map of the heart for use in cardiac ablation with catheter atop the map

Promising Early Experience With Dual-Energy Catheter Ablation of Ventricular Arrhythmias

Cleveland Clinic reports first U.S. series focused on use in this challenging setting

surgical team working at an operating table

Radical Pericardiectomy With Bypass Support Delivers the Best Outcomes in Constrictive Pericarditis

Large series confirms early and long-term survival advantages over partial pericardial resection

doctor looking at images on monitor during a heart procedure

Pulsed Field Ablation More Effective Than Medical Therapy for Initial Treatment of Persistent AF

AVANT GUARD trial extends first-line role for ablation beyond paroxysmal atrial fibrillation

woman on a bed grasping her chest in front of a doctor

AHA Statement Targets Gaps in ACS Care for Premenopausal Women

Maintain a high index of clinical suspicion and consider the underlying etiology

man lying on a gurney being rushed through a hospital

Standardizing STEMI Transfers: 4-Step Protocol Improves Care Processes and Survival

Protocol adoption at Cleveland Clinic sharply raised share of transferred patients getting timely PCI

Ad